Search Results - Julia Möllmann

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study

    Effects of empagliflozin on markers of calcium and phosphate homeostasis in patients with type 2 diabetes – Data from a randomized, placebo-controlled study by Matthias Rau, Kirsten Thiele, Niels‐Ulrik Korbinian Hartmann, Julia Möllmann, Stephanie Wied, Mathias Hohl, Nikolaus Marx, Michael Lehrke

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    ITCH modulates SIRT6 and SREBP2 to influence lipid metabolism and atherosclerosis in ApoE null mice

    ITCH modulates SIRT6 and SREBP2 to influence lipid metabolism and atherosclerosis in ApoE null mice by Robert Stöhr, Maria Mavilio, Arianna Marino, Viviana Casagrande, Ben A. Kappel, Julia Möllmann, Rossella Menghini, Gerry Melino, Massimo Federici

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Soluble CD74 Reroutes MIF/CXCR4/AKT‐Mediated Survival of Cardiac Myofibroblasts to Necroptosis

    Soluble CD74 Reroutes MIF/CXCR4/AKT‐Mediated Survival of Cardiac Myofibroblasts to Necroptosis by Josefin Soppert, Sandra Kraemer, Christian Beckers, Luisa Averdunk, Julia Möllmann, Bernd Denecke, Andreas Goetzenich, Gernot Marx, Jürgen Bernhagen, Christian Stoppe

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Hyperlipidemia-Induced MicroRNA-155-5p Improves β-Cell Function by Targeting<i>Mafb</i>

    Hyperlipidemia-Induced MicroRNA-155-5p Improves β-Cell Function by Targeting<i>Mafb</i> by Mengyu Zhu, Yuanyuan Wei, Claudia Geißler, Kathrin Abschlag, Judit Corbalán Campos, Michael Hristov, Julia Möllmann, Michael Lehrke, Ela Karshovska, Andreas Schober

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study

    Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized c... by Matthias Rau, Kirsten Thiele, Niels‐Ulrik Korbinian Hartmann, Alexander Schuh, Ertunc Altiok, Julia Möllmann, András Keszei, Michael Böhm, Nikolaus Marx, Michael Lehrke

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6–Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering

    GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6–Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering by Florian Kahles, C. Meyer, Julia Möllmann, Sebastian Diebold, Hannes M. Findeisen, Corinna Lebherz, Christian Trautwein, Alexander Koch, Frank Tacke, Nikolaus Marx, Michael Lehrke

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Impaired cellular energy metabolism in cord blood macrophages contributes to abortive response toward inflammatory threats

    Impaired cellular energy metabolism in cord blood macrophages contributes to abortive response toward inflammatory threats by Stephan Dreschers, Kim Ohl, Michael Lehrke, Julia Möllmann, Bernd Denecke, Ivan G. Costa, Thomas Vogl, Dorothee Viemann, Johannes Roth, Thorsten Orlikowsky, Klaus Tenbrock

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure

    Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure by Kirsten Thiele, Matthias Rau, Niels‐Ulrik Korbinian Hartmann, Marcus J. Möller, Julia Möllmann, Joachim Jankowski, András Keszei, Michael Böhm, Jürgen Floege, Nikolaus Marx, Michael Lehrke

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE−/− mice by blocking monocyte/macrophage activation

    The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE−/− mice by blocking monocyte/macrophage activation by Florian Kahles, Ana C. Liberman, C Halim, Matthias Rau, Julia Möllmann, R. Mertens, Marcia Viviane Rückbeil, Irmgard Diepolder, Benedikt Walla, Sebastian Diebold, Mathias Burgmaier, Corinna Lebherz, Nikolaus Marx, Michael Lehrke

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis

    Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis by Tanja Vajen, Rory R. Koenen, I. Werner, Mareike Staudt, Delia Projahn, Adelina Curaj, Tolga Taha Sönmez, Sakine Simsekyilmaz, David Schumacher, Julia Möllmann, Tilman M. Hackeng, Philipp von Hundelshausen, Christian Weber, Elisa A. Liehn

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis

    Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis by Kim Ohl, Athanassios Fragoulis, Patricia Klemm, Julian Baumeister, Wiebke Klock, Eva Verjans, Svenja Böll, Julia Möllmann, Michael Lehrke, Ivan G. Costa, Bernd Denecke, Angela Schippers, Johannes Roth, Norbert Wagner, Christoph Jan Wruck, Klaus Tenbrock

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease

    Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease by Stefan Schunk, Sarah Triem, David Schmit, Stephen Zewinger, Tamim Sarakpi, Ellen Becker, Gregor Hütter, Selina Wrublewsky, Fabienne Küting, Mathias Hohl, Dalia Alansary, Letícia Prates Roma, Peter Lipp, Julia Möllmann, Michael Lehrke, Matthias W. Laschke, Michael D. Menger, Rafael Kramann, Peter Boor, Willi Jahnen‐Dechent, Winfried März, Michael Böhm, Ulrich Laufs, Barbara A. Niemeyer, Danilo Fliser, Emmanuel Ampofo, Thimoteus Speer

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: